These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT. Kim DW, Park SA, Kim CG. J Korean Med Sci; 2011 Jul; 26(7):875-80. PubMed ID: 21738339 [Abstract] [Full Text] [Related]
4. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma. Rayamajhi S, Balachandran A, Katz M, Reddy A, Rohren E, Bhosale P. Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703 [Abstract] [Full Text] [Related]
6. Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection. Lee JW, Son MW, Chung IK, Cho YS, Lee MS, Lee SM. Gastric Cancer; 2020 Mar; 23(2):273-284. PubMed ID: 31485803 [Abstract] [Full Text] [Related]
8. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K. Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [Abstract] [Full Text] [Related]
9. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Chen J, Cheong JH, Yun MJ, Kim J, Lim JS, Hyung WJ, Noh SH. Cancer; 2005 Jun 01; 103(11):2383-90. PubMed ID: 15856477 [Abstract] [Full Text] [Related]
11. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Bhosale P, Peungjesada S, Wei W, Levenback CF, Schmeler K, Rohren E, Macapinlac HA, Iyer RB. Int J Gynecol Cancer; 2010 Aug 01; 20(6):936-44. PubMed ID: 20683399 [Abstract] [Full Text] [Related]
12. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125. Rubini G, Altini C, Notaristefano A, Merenda N, Rubini D, Ianora AA, Asabella AN. Rev Esp Med Nucl Imagen Mol; 2014 Aug 01; 33(1):22-7. PubMed ID: 23948509 [Abstract] [Full Text] [Related]
16. Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma. Lim JS, Kim MJ, Yun MJ, Oh YT, Kim JH, Hwang HS, Park MS, Cha SW, Lee JD, Noh SH, Yoo HS, Kim KW. Korean J Radiol; 2006 Aug 01; 7(4):249-56. PubMed ID: 17143028 [Abstract] [Full Text] [Related]
17. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT. Kim CK, Park BK, Choi JY, Kim BG, Han H. J Comput Assist Tomogr; 2007 Aug 01; 31(6):868-75. PubMed ID: 18043348 [Abstract] [Full Text] [Related]
18. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results. Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, Wu H. World J Gastroenterol; 2008 Aug 07; 14(29):4627-32. PubMed ID: 18698676 [Abstract] [Full Text] [Related]
20. Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection. Lee JW, Lee SM, Son MW, Lee MS. Eur J Nucl Med Mol Imaging; 2016 May 07; 43(5):881-888. PubMed ID: 26611426 [Abstract] [Full Text] [Related] Page: [Next] [New Search]